MedTrace Logo

Clinical Testing Study in Peripheral Arterial Disease

NCT05243992 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-02-17

No results posted yet for this study

Summary

The Purpose of the Clinical Testing Study in Peripheral Arterial Disease (CTS-PAD) study is to compare measurement outcomes between conventional Ankle-Brachial Index test for Peripheral Arterial Disease with a new imaging technology from which the same data can be derived, in a series of patients referred to Vascular Surgery Clinics at the University of Rochester for suspected peripheral arterial disease.

Conditions

  • Peripheral Arterial Disease

Interventions

OTHER

CTS-PAD device imaging

Participants in the CTS-PAD Study will undergo a conventional ABI (cABI) evaluation, followed by the non-contact imaging evaluation with the CTS-PAD device. The supplemental CTS-PAD testing will add approximately ten (10) minutes to the overall evaluation time.

Sponsors & Collaborators

  • University of Rochester

    collaborator OTHER

  • Perfusio Corp.

    lead INDUSTRY

Principal Investigators

  • Thomas B Ferguson, MD · Perfusio Corp.

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2022-09-30
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05243992 on ClinicalTrials.gov